dalteparin has been researched along with Diabetic Retinopathy in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intraoperative bleeding, postoperative fibrin, hyphema and vitreous hemorrhage were graded in an unmasked fashion using previously described grading scales." | 3.73 | A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy. ( Jumper, JM; Lane, RG; MacCumber, MW; McCuen, BW; Nasir, MA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilhan, O | 1 |
| Ilhan, N | 1 |
| Coşkun, M | 1 |
| Dağlioğlu, MC | 1 |
| Ayhan Tuzcu, E | 1 |
| Ayintap, E | 1 |
| Keskın, U | 1 |
| Oksüz, H | 1 |
| Lane, RG | 1 |
| Jumper, JM | 1 |
| Nasir, MA | 1 |
| MacCumber, MW | 1 |
| McCuen, BW | 1 |
1 trial available for dalteparin and Diabetic Retinopathy
| Article | Year |
|---|---|
The effect of enoxaparin-containing irrigation fluid used during cataract surgery on postoperative inflammation in patients with diabetes.
Topics: Aged; Anterior Chamber; Anticoagulants; Cataract; Cataract Extraction; Diabetes Mellitus; Diabetic R | 2013 |
1 other study available for dalteparin and Diabetic Retinopathy
| Article | Year |
|---|---|
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.
Topics: Diabetic Retinopathy; Enoxaparin; Female; Fibrin; Fibrinolytic Agents; Humans; Hyphema; Infusion Pum | 2005 |